SCHEMBL94031

SCHEMBL94031

[CH]=CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL543079 0.84
SCHEMBL542410 0.84
SCHEMBL7362019 0.83
SCHEMBL7359812 0.83
SCHEMBL3086518 0.81
SCHEMBL42834 0.81
SCHEMBL7360060 0.76
SCHEMBL5580750 0.67
SCHEMBL3233261 0.65
SCHEMBL4351456 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430622-A Derivatives of heterocyclic compounds as pest control agents 拜耳公司 2024-01-23 CN claimed
CN-111433215-B Derivatives of heterocyclic compounds as pest control agents 拜耳公司 2023-10-03 CN claimed
EP-3864015-B1 PROCESS FOR THE PREPARATION OF IMIDAZOLE DERIVATEIVES BAYER AG (DE) 2023-05-10 EP claimed
CN-110312718-B Heterocyclene derivatives as pest control agents 拜耳公司 2023-02-28 CN claimed
EP-3864016-B1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES BAYER AG (DE) 2022-09-14 EP claimed
US-20220009930-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2022-01-13 US claimed
US-20210380611-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2021-12-09 US claimed
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-12-02 US claimed
EP-3864016-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 EP claimed
EP-3864015-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 EP claimed
EP-2139354-A2 ORGANIC COMPOUNDS Givaudan SA (CH) 2010-01-06 EP claimed
WO-2008137816-A2 TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS WYETH (US) 2008-11-13 WO claimed
WO-2008116339-A2 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2008-10-02 WO claimed
WO-2007001406-A2 ARYL-CONTAINING MACROCYCLIC COMPOUNDS CHIRON CORPORATION (US) 2007-01-04 WO claimed
EP-1737458-A2 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF The McLean Hospital Corporation (US) 2007-01-03 EP claimed
US-20060040900-A1 R(-)-11-hydroxyaporphine derivatives and uses thereof MCLEAN HOSPITAL CORPORATION, THE 2006-02-23 US claimed
WO-2005099702-A2 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF THE MCLEAN HOSPITAL CORPORATION (US) 2005-10-27 WO claimed
CN-1200917-C Process for preparation of cyclopropyl acethlene derivative KURARAY CO (JP) 2005-05-11 CN claimed
CN-1281840-A Process for preparation of cyclopropyl acethlene derivative KURARAY CO (JP) 2001-01-31 CN claimed
CN-1191856-A Process for preparing cyclopropyl acetylene derivatives KURARAY CO (JP) 1998-09-02 CN claimed